These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25326399)

  • 41. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
    Houlden H; Reilly MM
    Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
    Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
    Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Molecular diagnosis of axonal forms of Charcot-Marie-Tooth disease].
    Latour P; Vial C
    Rev Neurol (Paris); 2009 Dec; 165(12):1122-6. PubMed ID: 19942244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE.
    Beauvais K; Furby A; Latour P
    Neuromuscul Disord; 2006 Jan; 16(1):14-8. PubMed ID: 16373087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review.
    Yalcouyé A; Esoh K; Guida L; Wonkam A
    J Peripher Nerv Syst; 2022 Jun; 27(2):100-112. PubMed ID: 35383421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease.
    Kim HJ; Hong YB; Park JM; Choi YR; Kim YJ; Yoon BR; Koo H; Yoo JH; Kim SB; Park M; Chung KW; Choi BO
    Orphanet J Rare Dis; 2013 Jul; 8():104. PubMed ID: 23844677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth families: ten novel mutations.
    Nicholson GA; Yeung L; Corbett A
    Neurology; 1998 Nov; 51(5):1412-6. PubMed ID: 9818870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Charcot-Marie-Tooth disease: frequency of genetic subtypes in a Southern Italy population.
    Manganelli F; Tozza S; Pisciotta C; Bellone E; Iodice R; Nolano M; Geroldi A; Capponi S; Mandich P; Santoro L
    J Peripher Nerv Syst; 2014 Dec; 19(4):292-8. PubMed ID: 25429913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proof of genetic heterogeneity in X-linked Charcot-Marie-Tooth disease.
    Huttner IG; Kennerson ML; Reddel SW; Radovanovic D; Nicholson GA
    Neurology; 2006 Dec; 67(11):2016-21. PubMed ID: 17159110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutation testing in Charcot-Marie-Tooth neuropathy.
    Nicholson GA
    Ann N Y Acad Sci; 1999 Sep; 883():383-8. PubMed ID: 10586262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel INF2 mutation in a Korean family with autosomal dominant intermediate Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis.
    Park HJ; Kim HJ; Hong YB; Nam SH; Chung KW; Choi BO
    J Peripher Nerv Syst; 2014 Jun; 19(2):175-9. PubMed ID: 24750328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel GJB1 mutation causing adult-onset Charcot-Marie-Tooth disease in a female patient.
    Martikainen MH; Majamaa K
    Neuromuscul Disord; 2013 Nov; 23(11):899-901. PubMed ID: 23838279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and molecular studies in a family with probable X-linked dominant Charcot-Marie-Tooth disease involving the central nervous system.
    Hisama FM; Lee HH; Vashlishan A; Tekumalla P; Russell DS; Auld E; Goldstein JM
    Arch Neurol; 2001 Nov; 58(11):1891-6. PubMed ID: 11709000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Charcot-Marie-Tooth disease: Genetic profile of patients from a large Brazilian neuromuscular reference center.
    Uchôa Cavalcanti EB; Santos SCL; Martins CES; de Carvalho DR; Rizzo IMPO; Freitas MCDNB; da Silva Freitas D; de Souza FS; Junior AM; do Nascimento OJM
    J Peripher Nerv Syst; 2021 Sep; 26(3):290-297. PubMed ID: 34190362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype.
    Abe A; Numakura C; Saito K; Koide H; Oka N; Honma A; Kishikawa Y; Hayasaka K
    J Hum Genet; 2009 Feb; 54(2):94-7. PubMed ID: 19158810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and genetic characterization of NEFL-related neuropathy in Taiwan.
    Chao HC; Hsiao CT; Lai KL; Tsai YS; Lin KP; Liao YC; Lee YC
    J Formos Med Assoc; 2023 Feb; 122(2):132-138. PubMed ID: 36031490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel homozygous nonsense mutation in NEFL causes autosomal recessive Charcot-Marie-Tooth disease.
    Fu J; Yuan Y
    Neuromuscul Disord; 2018 Jan; 28(1):44-47. PubMed ID: 29191368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic and phenotypic profile of 112 patients with X-linked Charcot-Marie-Tooth disease type 1.
    Yuan JH; Sakiyama Y; Hashiguchi A; Ando M; Okamoto Y; Yoshimura A; Higuchi Y; Takashima H
    Eur J Neurol; 2018 Dec; 25(12):1454-1461. PubMed ID: 29998508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leukoencephalopathy and conduction blocks in PLEKHG5-associated intermediate CMT disease.
    Villar-Quiles RN; Le VT; Leonard-Louis S; Trang NT; Huong NT; Laddada L; Francou B; Maisonobe T; Azzedine H; Stojkovic T
    Neuromuscul Disord; 2021 Aug; 31(8):756-764. PubMed ID: 34244018
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.